678 related articles for article (PubMed ID: 8645382)
1. Advantages of larger volume, less frequent intrauterine red blood cell transfusions for maternal red cell alloimmunization.
Inglis SR; Lysikiewicz A; Sonnenblick AL; Streltzoff JL; Bussel JB; Chervenak FA
Am J Perinatol; 1996 Jan; 13(1):27-33. PubMed ID: 8645382
[TBL] [Abstract][Full Text] [Related]
2. Complications of intrauterine intravascular transfusion for fetal anemia due to maternal red-cell alloimmunization.
Van Kamp IL; Klumper FJ; Oepkes D; Meerman RH; Scherjon SA; Vandenbussche FP; Kanhai HH
Am J Obstet Gynecol; 2005 Jan; 192(1):171-7. PubMed ID: 15672021
[TBL] [Abstract][Full Text] [Related]
3. Treatment of fetal anemia due to red-cell alloimmunization with intrauterine transfusions in the Netherlands, 1988-1999.
van Kamp IL; Klumper FJ; Meerman RH; Oepkes D; Scherjon SA; Kanhai HH
Acta Obstet Gynecol Scand; 2004 Aug; 83(8):731-7. PubMed ID: 15255845
[TBL] [Abstract][Full Text] [Related]
4. Early intraperitoneal transfusion and adjuvant maternal immunoglobulin therapy in the treatment of severe red cell alloimmunization prior to fetal intravascular transfusion.
Fox C; Martin W; Somerset DA; Thompson PJ; Kilby MD
Fetal Diagn Ther; 2008; 23(2):159-63. PubMed ID: 18046076
[TBL] [Abstract][Full Text] [Related]
5. [Perinatal management and neurological outcome of newborns hospitalized with Rhesus hemolytic disease].
Gobalakichenane P; Lardennois C; Galène-Gromez S; Brossard V; Marpeau L; Verspyck E; Marret S;
Gynecol Obstet Fertil; 2008 Oct; 36(10):984-90. PubMed ID: 18804397
[TBL] [Abstract][Full Text] [Related]
6. Albumin and packed red blood cells in the treatment of severely isoimmunised pregnancies.
Marianowski L; Debski R; Rokicki T; Pasek K; Lukaszewicz E; Gromadzki J
Mater Med Pol; 1992; 24(4):260-1. PubMed ID: 1308057
[TBL] [Abstract][Full Text] [Related]
7. Rh disease: intrauterine intravascular fetal blood transfusion by cordocentesis.
Onderoğlu L; Oncüloğlu C
Turk J Pediatr; 1999; 41(1):61-5. PubMed ID: 10770677
[TBL] [Abstract][Full Text] [Related]
8. Intrauterine intravascular transfusion for severe erythroblastosis fetalis: how much to transfuse?
Plecas DV; Chitkara U; Berkowitz GS; Lapinski RH; Alvarez M; Berkowitz RL
Obstet Gynecol; 1990 Jun; 75(6):965-9. PubMed ID: 2342745
[TBL] [Abstract][Full Text] [Related]
9. High additional maternal red cell alloimmunization after Rhesus- and K-matched intrauterine intravascular transfusions for hemolytic disease of the fetus.
Schonewille H; Klumper FJ; van de Watering LM; Kanhai HH; Brand A
Am J Obstet Gynecol; 2007 Feb; 196(2):143.e1-6. PubMed ID: 17306657
[TBL] [Abstract][Full Text] [Related]
10. Fetal outcome following intrauterine intravascular transfusion in rhesus alloimmunization.
Merchant RH; Lulla CP; Gupte SC; Krishnani RH
Indian Pediatr; 1995 Sep; 32(9):971-7. PubMed ID: 8935259
[TBL] [Abstract][Full Text] [Related]
11. Early intrauterine transfusion in severe red blood cell alloimmunization.
Yinon Y; Visser J; Kelly EN; Windrim R; Amsalem H; Seaward PG; Ryan G
Ultrasound Obstet Gynecol; 2010 Nov; 36(5):601-6. PubMed ID: 20509139
[TBL] [Abstract][Full Text] [Related]
12. Procedure-related complications and perinatal outcome after intrauterine transfusions in red cell alloimmunization in Stockholm.
Tiblad E; Kublickas M; Ajne G; Bui TH; Ek S; Karlsson A; Wikman A; Westgren M
Fetal Diagn Ther; 2011; 30(4):266-73. PubMed ID: 22024691
[TBL] [Abstract][Full Text] [Related]
13. Fetal transfusion for red blood cell alloimmunization in pregnancy.
Schumacher B; Moise KJ
Obstet Gynecol; 1996 Jul; 88(1):137-50. PubMed ID: 8684747
[TBL] [Abstract][Full Text] [Related]
14. An audit of outcome in intravascular transfusions using the intrahepatic portion of the fetal umbilical vein compared to cordocentesis.
Somerset DA; Moore A; Whittle MJ; Martin W; Kilby MD
Fetal Diagn Ther; 2006; 21(3):272-6. PubMed ID: 16601337
[TBL] [Abstract][Full Text] [Related]
15. Intrauterine transfusion with red cells and platelets.
Moise KJ
West J Med; 1993 Sep; 159(3):318-24. PubMed ID: 8236973
[TBL] [Abstract][Full Text] [Related]
16. [Maternal blood intrauterine transfusions in the therapy of red-cell alloimmunization performed in three difficult cases].
Kucińska-Chahwan A; Massalska D; Bijok J; Rudzińska M; Kopeć I; Rzymkiewicz L; Jakiel G; Roszkowski T
Ginekol Pol; 2014 Sep; 85(9):703-7. PubMed ID: 25322544
[TBL] [Abstract][Full Text] [Related]
17. Prediction of the rate of decline in fetal hemoglobin levels between first and second transfusions in red cell alloimmune disease.
Nishie EN; Liao AW; Brizot Mde L; Assunção RA; Zugaib M
Prenat Diagn; 2012 Dec; 32(12):1123-6. PubMed ID: 22949399
[TBL] [Abstract][Full Text] [Related]
18. Pediatric outcome in Rhesus hemolytic disease treated with and without intrauterine transfusion.
De Boer IP; Zeestraten EC; Lopriore E; van Kamp IL; Kanhai HH; Walther FJ
Am J Obstet Gynecol; 2008 Jan; 198(1):54.e1-4. PubMed ID: 18166305
[TBL] [Abstract][Full Text] [Related]
19. Combined plasmapheresis and intravenous immune globulin for the treatment of severe maternal red cell alloimmunization.
Ruma MS; Moise KJ; Kim E; Murtha AP; Prutsman WJ; Hassan SS; Lubarsky SL
Am J Obstet Gynecol; 2007 Feb; 196(2):138.e1-6. PubMed ID: 17306655
[TBL] [Abstract][Full Text] [Related]
20. Experience with intrauterine transfusions for severe Rh alloimmunization in a developing country.
Gupte SC; Lulla CP; Kulkarni SS; Korgaonkar SA; Walvekar VR; Merchant RH
J Matern Fetal Med; 1998; 7(6):287-91. PubMed ID: 9848694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
